<?xml version="1.0" encoding="UTF-8"?>
<p>Another main point is represented by the evolution and the adaptive mutations of the virus [
 <xref rid="B6-molecules-26-00632" ref-type="bibr">6</xref>]. Indeed, the presence of SARS-CoV-2 Spike mutations can affect the interaction with the human epithelial cell receptors Angiotensin Converting Enzyme 2 (ACE2). The question of whether this would correspond to a novel and more potent COVID-19 specificities eventually requiring the development of wider-spectrum anti-SARS-CoV-2 strategies, such as vaccines or antiviral drugs, remains open [
 <xref rid="B7-molecules-26-00632" ref-type="bibr">7</xref>,
 <xref rid="B8-molecules-26-00632" ref-type="bibr">8</xref>,
 <xref rid="B9-molecules-26-00632" ref-type="bibr">9</xref>].
</p>
